Paul Hartmann AG
F:PHH2

Watchlist Manager
Paul Hartmann AG Logo
Paul Hartmann AG
F:PHH2
Watchlist
Price: 212 EUR
Market Cap: €756.8m

Profitability Summary

Paul Hartmann AG's profitability score is 49/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

49 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

49 / 100
Profitability
Score
49 / 100
Profitability
Score

Margins

Earnings Waterfall
Paul Hartmann AG

Margins Comparison
Paul Hartmann AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Paul Hartmann AG
F:PHH2
753m EUR
Loading...
Loading...
Loading...
US
Medline Inc
NASDAQ:MDLN
58.5B USD
Loading...
Loading...
Loading...
JP
Hoya Corp
TSE:7741
9.3T JPY
Loading...
Loading...
Loading...
CH
Alcon AG
SIX:ALC
28.9B CHF
Loading...
Loading...
Loading...
DK
Coloplast A/S
CSE:COLO B
98.4B DKK
Loading...
Loading...
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.2B USD
Loading...
Loading...
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
930B JPY
Loading...
Loading...
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD
Loading...
Loading...
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
38.6B CNY
Loading...
Loading...
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.2B GBP
Loading...
Loading...
Loading...
CN
Intco Medical Technology Co Ltd
SZSE:300677
38.4B CNY
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Paul Hartmann AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Paul Hartmann AG
F:PHH2
753m EUR
Loading...
Loading...
Loading...
Loading...
US
Medline Inc
NASDAQ:MDLN
58.5B USD
Loading...
Loading...
Loading...
Loading...
JP
Hoya Corp
TSE:7741
9.3T JPY
Loading...
Loading...
Loading...
Loading...
CH
Alcon AG
SIX:ALC
28.9B CHF
Loading...
Loading...
Loading...
Loading...
DK
Coloplast A/S
CSE:COLO B
98.4B DKK
Loading...
Loading...
Loading...
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.2B USD
Loading...
Loading...
Loading...
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
930B JPY
Loading...
Loading...
Loading...
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD
Loading...
Loading...
Loading...
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
38.6B CNY
Loading...
Loading...
Loading...
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.2B GBP
Loading...
Loading...
Loading...
Loading...
CN
Intco Medical Technology Co Ltd
SZSE:300677
38.4B CNY
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Paul Hartmann AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett